In the present study, plasma concentrations of IL-1RA, IL-17A, IL-6, IL-8, and IL-10 were significantly higher in NSCLC patients compared to healthy controls, and markedly elevated relative to COPD patients, highlighting their specificity to malignancy-associated inflammation. This evidence concerns the gene IL17A and non-small cell lung carcinoma.